Coronary artery disease
|
|
|
- Morgan Jackson
- 8 years ago
- Views:
Transcription
1 Oxford Medicine Online You are looking at 1-8 of 8 items for: UA oxford_medical_handbooks CAR0040 Coronary artery disease Punit Ramrakha and Jonathan Hill (eds) Print Publication Year: 2012 Published Online: May 2012 ISBN: eisbn: DOI: /med/ Atherosclerosis: pathophysiology - Development of atherosclerotic plaques - Epidemiology - Assessment of atherosclerotic risk - Risk factors for coronary artery disease - Hypertension - Treatment of high blood pressure - Combining antihypertensive drugs - Lipid management in atherosclerosis - Lipid-lowering therapy - When to treat lipids - Diabetes and atherosclerosis - The metabolic syndrome and insulin resistance - Metabolic syndrome: management - Angina pectoris - Acute coronary syndromes - ST elevation myocardial infarction (STEMI) - STEMI: diagnosis - STEMI: general measures - STEMI: reperfusion therapy (thrombolysis) - STEMI: reperfusion by primary PCI - Surgery for acute STEMI - STEMI: additional measures - Right ventricular infarction - STEMI: predischarge risk stratification - STEMI: complications - Ventricular septal defect post-mi - Acute mitral regurgitation post-mi - Pseudoaneurysm and free-wall rupture - Cocaineinduced MI - Ventricular tachyarrhythmias post-mi - Atrial tachyarrhythmias post-mi - Bradyarrhythmias and indications for pacing - Bradyarrhythmias post-mi - Hypotension and shock post-mi - Cardiogenic shock - Non-ST elevation myocardial infarction (NSTEMI)/ unstable angina (UA) - NSTEMI/UA: diagnosis - NSTEMI/UA: risk stratification - NSTEMI/UA: late risk stratification - NSTEMI/UA: medical management - NSTEMI/UA: invasive versus non-invasive strategies - NSTEMI/UA: discharge and secondary prevention - Genetics of coronary artery disease: introduction - Monogenic causes of coronary artery disease - Genes conferring increased risk of coronary artery disease (polygenic CAD) - Genetic testing for coronary artery disease - Cardiac emergencies Punit S. Ramrakha, Kevin P. Moore, and Amir Sam Print Publication Year: 2010 Published Online: Aug 2010 ISBN: eisbn: DOI: /med/ Adult basic life support - Adult advanced life support - Universal treatment algorithm - Acute coronary syndrome (ACS) - ST elevation myocardial infarction (STEMI) - STEMI: diagnosis 1 - STEMI: diagnosis 2 - STEMI: general measures - STEMI: reperfusion therapy (thrombolysis) 1 - STEMI: thrombolysis 2 - STEMI: reperfusion by primary percutaneous Page 1 of 5
2 coronary intervention (PCI) - Surgery for acute STEMI - STEMI: additional measures - Right ventricular (RV) infarction - STEMI: predischarge risk stratification - STEMI: complications - Ventricular septal defect post myocardial infarction (MI) - Acute mitral regurgitation post MI - Pseudoaneurysm and free wall rupture - Cocaine-induced MI - Ventricular tachyarrhythmia post MI - Atrial tachyarrhythmia post MI - Bradyarrhythmias and indications for pacing - Bradyarrhythmias post MI - Hypotension and shock post MI - Cardiogenic shock - Non-ST elevation myocardial infarction (NSTEMI)/unstable angina (UA) - NSTEMI/UA: diagnosis - NSTEMI/UA: risk stratification - NSTEMI/UA: late risk stratification - NSTEMI/UA: medical management 1 - NSTEMI/UA: medical management 2 - NSTEMI/UA: invasive versus non-invasive strategies - NSTEMI/UA: discharge and secondary prevention - Arrhythmias: general approach - Tachyarrhythmias heart rate (HR) >120bpm - Treatment options in tachyarrhythmias - Broad complex tachycardia: diagnosis - Monomorphic ventricular tachycardia (MVT) - Polymorphic ventricular tachycardia (PVT) - Ventricular tachycardia: drugs - Narrow complex tachyarrhythmias (SVT) - Dosages of selected antiarrhythmics for SVT - Atrial fibrillation (AF): assessment - AF: management - AF: rate control - Atrial flutter - Multifocal atrial tachycardia (MAT) - Accessory pathway tachycardia (AV re-entrant tachycardia, AVRT) - Atrioventricularnodal re-entry tachycardia (AVNRT) - Bradyarrhythmias: general approach - Sinus bradycardia or junctional rhythm - Intraventricular conduction disturbances - Types of atrioventricular (AV) conduction block - Pulmonary oedema: assessment - Pulmonary oedema: causes - Pulmonary oedema: management 1 - Pulmonary oedema: management 2 - Pulmonary oedema: management 3 - Pulmonary oedema: specific conditions - Infective endocarditis (IE) - IE: diagnosis - IE: investigations - IE: antibiotics - IE: monitoring treatment - Culture-negative endocarditis - Right-sided endocarditis - Prosthetic valve endocarditis (PVE) - Surgery for IE - Endocarditis prophylaxis - Acute aortic regurgitation (AR) - Acute mitral regurgitation (MR) - Deep vein thrombosis (DVT): assessment - DVT: management - Pulmonary embolism (PE): assessment - PE: investigations 1 - PE: investigations 2 - Pulmonary embolism: management 1 - Pulmonary embolism: management 2 - Fat embolism - Hypertensive emergencies - Hypertensive emergencies: management - Hypertensive emergencies: drug treatment - Hypertensive emergency with retinopathy (accelerated and malignant hypertension) - Hypertensive encephalopathy - Aortic dissection: assessment - Aortic dissection: investigations - Aortic dissection: management 1 - Aortic dissection: management 2 - Acute pericarditis: assessment - Acute pericarditis: management - Bacterial pericarditis - Cardiac tamponade: presentation - Cardiac tamponade: management - Congenital heart disease in adults 1 - Congenital heart disease in adults 2 Cardiovascular Tim Raine, James Dawson, Stephan Sanders, and Simon Eccles Print Publication Year: 2014 Published Online: Aug 2014 ISBN: eisbn: DOI: /med/ Page 2 of 5
3 Cardiovascular emergencies Punit Ramrakha and Jonathan Hill (eds) Print Publication Year: 2012 Published Online: May 2012 ISBN: eisbn: DOI: /med/ Adult basic life support - Adult advanced life support - Universal treatment algorithm - Primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction - Acute MI: thrombolysis protocol - Acute myocardial infarction - Treatment options in tachyarrhythmias - Ventricular tachycardia: drugs - Supraventricular tachyarrhythmias - Acute pulmonary oedema: assessment - Pulmonary oedema: causes - Pulmonary oedema: management - Pulmonary oedema: specific conditions - Acute aortic regurgitation - Acute mitral regurgitation - Deep vein thrombosis: assessment - Deep vein thrombosis: management - Pulmonary embolism: assessment - Pulmonary embolism: investigations - Pulmonary embolism: management - Fat embolism - Hypertensive emergencies - Hypertensive emergencies: management - Drugs for hypertensive emergencies - Hypertensive emergency with retinopathy (accelerated and malignant hypertension) - Hypertensive encephalopathy - Aortic dissection: assessment - Aortic dissection: investigations - Aortic dissection: management - Acute pericarditis: assessment - Acute pericarditis: management - Cardiac tamponade: presentation - Cardiac tamponade: management - Therapy-related issues: infections Philip Wiffen, Marc Mitchell, Melanie Snelling, and Nicola Stoner Print Publication Year: 2012 Published Online: Jan 2012 ISBN: eisbn: DOI: /med/ Basic microbiology - Modes of action of antibacterials - Selection and use of antimicrobials - Antimicrobial prophylaxis - Optimizing antimicrobial use - Antimicrobial prescribing guidelines - Antimicrobial resistance - Infection control Cardiovascular system Duncan Richards, Jamie Coleman, John Reynolds, and Jeffrey Aronson Print Publication Year: 2011 Published Online: Jan 2012 ISBN: eisbn: DOI: /med/ Contents A pharmacological approach to the treatment of arrhythmias BNF Antiarrhythmic drugsadenosine BNF Flecainide BNF Cardiac glycosides (digitalis) BNF 2.1.1, 2.3.1, and Disopyramide BNF Amiodarone BNF and Anticoagulants, antiplatelet drugs, and fibrinolytic drugsheparins (unfractionated and low molecular weight) BNF Direct thrombin inhibitors BNF Fondaparinux Page 3 of 5
4 sodium BNF Warfarin BNF Acetylsalicylic acid (aspirin) BNF 2.9 and Clopidogrel BNF Dipyridamole BNF Glycoprotein IIb/IIIa antagonists BNF Fibrinolytic drugs BNF and Ischaemic heart diseasepharmacology of drugs used to treat acute coronary syndromes, including myocardial infarction BNF Pharmacology of drugs used to treat heart failure - Nitrate drugs BNF Nicorandil BNF Beta-adrenoceptor antagonists ( beta-blockers ) BNF 2.4, 2.5.5, 6.2.2, 4.7.4, Angiotensin converting enzyme inhibitors (ACE inhibitors) BNF Angiotensin receptor antagonists/blockers (ARBs) BNF HypertensionAn approach to the treatment of hypertension BNF Methyldopa (alpha-methyldopa) BNF Calcium channel blockerscalcium channel blockers (see also individual sections) BNF Dihydropyridines (nifedipine-like) BNF Benzothiazepines (diltiazem) BNF and Phenylalkylamines (verapamil) BNF and Intravenous fluidscrystalloid solutions for intravenous infusion BNF Colloid solutions for intravenous infusion BNF DiureticsSites of action of diuretics BNF Treatment of pulmonary oedema BNF - Loop diuretics BNF and Thiazide and thiazide-like diuretics BNF 2.2.1, 2.5.5, and Potassiumsparing diuretics (amiloride and triamterene) BNF and Spironolactone and eplerenone BNF 2.2.3, 2.2.4, and Adrenoceptor agonistsadrenoceptor agonists (sympathomimetics) BNF Antimuscarinic drugsmuscarinic acetylcholine receptor antagonists (atropine and related compounds) BNF , 4.6, 4.9.2, 7.4.2, and Endothelin receptor antagonistsendothelin receptor antagonists BNF Drugs for erectile dysfunctionphosphodiesterase type V inhibitors BNF Also see Chapter 15 Respiratory disease Lara Herbert and Bruce McCormick Print Publication Year: 2015 Published Online: Jan 2016 ISBN: eisbn: DOI: /med/ This chapter describes the anaesthetic management of the patient with respiratory disease. It describes the assessment of respiratory function and preoperative respiratory investigations, and ventilatory strategies to reduce pulmonary complications. Common respiratory conditions covered include respiratory tract infection, smoking, asthma, chronic obstructive pulmonary disease, bronchiectasis, cystic fibrosis, obstructive sleep apnoea, sarcoidosis, restrictive pulmonary disease, and the patient with a transplanted lung. For each topic, preoperative investigation and optimization, treatment, and anaesthetic management are described. Recommendations for the patient who may require post-operative respiratory support (e.g. non-invasive ventilation) are provided. Regional anaesthesia Adam Shonfeld and William Harrop-Griffiths Print Publication Year: 2015 Published Online: Jan 2016 ISBN: eisbn: DOI: /med/ Page 4 of 5
5 This chapter discusses the techniques of regional anaesthesia and analgesia. It begins with an overview of regional anaesthesia and goes on to describe safe practice and local anaesthetic agents. Techniques of locating nerves are then discussed, including ultrasound, and needle design is explored. Nerve blocks of the neck, upper limb, trunk, lower limb, and the neuraxis (spine) are described. Coagulation disorders, nerve injury, and the management of local anaesthetic toxicity are discussed. The chapter concludes with a dermatome map and tables of recommended nerve blocks for particular operations. Page 5 of 5
NAME OF THE HOSPITAL: 1. Coronary Balloon Angioplasty: M7F1.1/ Angioplasty with Stent(PTCA with Stent): M7F1.3
1. Coronary Balloon Angioplasty: M7F1.1/ Angioplasty with Stent(PTCA with Stent): M7F1.3 1. Name of the Procedure: Coronary Balloon Angioplasty 2. Select the Indication from the drop down of various indications
Coronary Artery Disease leading cause of morbidity & mortality in industrialised nations.
INTRODUCTION Coronary Artery Disease leading cause of morbidity & mortality in industrialised nations. Although decrease in cardiovascular mortality still major cause of morbidity & burden of disease.
Adult Cardiac Surgery ICD9 to ICD10 Crosswalks
164.1 Malignant neoplasm of heart C38.0 Malignant neoplasm of heart 164.1 Malignant neoplasm of heart C45.2 Mesothelioma of pericardium 198.89 Secondary malignant neoplasm of other specified sites C79.89
Diagnosis Code Crosswalk : ICD-9-CM to ICD-10-CM Cardiac Rhythm and Heart Failure Diagnoses
Diagnosis Code Crosswalk : to 402.01 Hypertensive heart disease, malignant, with heart failure 402.11 Hypertensive heart disease, benign, with heart failure 402.91 Hypertensive heart disease, unspecified,
UNIVERSITA' DEGLI STUDI DI ROMA TOR VERGATA
SYSTEMATIC PATHOLOGY I IIIYear Scientific Field DISCIPLINE TUTOR Systematic Pathology I MED/21 MED/10 Thoracic Surgery Respiratory Diseases Tommaso Claudio Mineo Paola Rogliani MED/10 Respiratory Diseases
8 Peri-arrest arrhythmias
8 Peri-arrest arrhythmias Introduction Cardiac arrhythmias are relatively common in the peri-arrest period. They are common in the setting of acute myocardial infarction and may precipitate ventricular
F.E.E.A. FONDATION EUROPEENNE D'ENSEIGNEMENT EN ANESTHESIOLOGIE FOUNDATION FOR EUROPEAN EDUCATION IN ANAESTHESIOLOGY
créée sous le Patronage de l'union Européenne Detailed plan of the program of six courses 1. RESPIRATORY 1. ESPIRATORY AND THORAX 1.1 Physics and principles of measurement 1.1.1 Physical laws 1.1.2 Vaporizers
Atrial fibrillation. Quick reference guide. Issue date: June 2006. The management of atrial fibrillation
Quick reference guide Issue date: June 2006 Atrial fibrillation The management of atrial fibrillation Developed by the National Collaborating Centre for Chronic Conditions Contents Contents Patient-centred
Atrial Fibrillation Peter Santucci, MD Revised May, 2008
Atrial Fibrillation Peter Santucci, MD Revised May, 2008 Atrial fibrillation (AF) is an irregular, disorganized rhythm characterized by a lack of organized mechanical atrial activity. The atrial rate is
Atrial Fibrillation Based on ESC Guidelines. Moshe Swissa MD Kaplan Medical Center
Atrial Fibrillation Based on ESC Guidelines Moshe Swissa MD Kaplan Medical Center Epidemiology AF affects 1 2% of the population, and this figure is likely to increase in the next 50 years. AF may long
PRACTICAL APPROACH TO SVT. Graham C. Wong MD MPH Division of Cardiology Vancouver General Hospital University of British Columbia
PRACTICAL APPROACH TO SVT Graham C. Wong MD MPH Division of Cardiology Vancouver General Hospital University of British Columbia CONDUCTION SYSTEM OF THE HEART SA node His bundle Left bundle AV node Right
ATRIAL FIBRILLATION (RATE VS RHYTHM CONTROL)
ATRIAL FIBRILLATION (RATE VS RHYTHM CONTROL) By Prof. Dr. Helmy A. Bakr Mansoura Universirty 2014 AF Classification: Mechanisms of AF : Selected Risk Factors and Biomarkers for AF: WHY AF? 1. Atrial fibrillation
The largest clinical study of Bayer's Xarelto (rivaroxaban) Wednesday, 14 November 2012 07:38
Bayer HealthCare has announced the initiation of the COMPASS study, the largest clinical study of its oral anticoagulant Xarelto (rivaroxaban) to date, investigating the prevention of major adverse cardiac
Ischemic Heart Disease: Angina Pectoris
Ischemic Heart Disease: Angina Pectoris Robert J. Straka, Pharm.D. FCCP Associate Professor University of Minnesota College of Pharmacy Minneapolis, Minnesota, USA strak001@umn.edu Learning Objectives
Protocol for the management of atrial fibrillation in primary care
Protocol for the management of atrial fibrillation in primary care Protocol for the management of atrial fibrillation in primary care Contents Page no Definition 2 Classification of AF 2 3 Identification
ACLS PHARMACOLOGY 2011 Guidelines
ACLS PHARMACOLOGY 2011 Guidelines ADENOSINE Narrow complex tachycardias or wide complex tachycardias that may be supraventricular in nature. It is effective in treating 90% of the reentry arrhythmias.
Medical management of CHF: A New Class of Medication. Al Timothy, M.D. Cardiovascular Institute of the South
Medical management of CHF: A New Class of Medication Al Timothy, M.D. Cardiovascular Institute of the South Disclosures Speakers Bureau for Amgen Background Chronic systolic congestive heart failure remains
Treating AF: The Newest Recommendations. CardioCase presentation. Ethel s Case. Wayne Warnica, MD, FACC, FACP, FRCPC
Treating AF: The Newest Recommendations Wayne Warnica, MD, FACC, FACP, FRCPC CardioCase presentation Ethel s Case Ethel, 73, presents with rapid heart beating and mild chest discomfort. In the ED, ECG
Atrial Fibrillation Management Across the Spectrum of Illness
Disclosures Atrial Fibrillation Management Across the Spectrum of Illness NONE Barbara Birriel, MSN, ACNP-BC, FCCM The Pennsylvania State University Objectives AF Discuss the pathophysiology, diagnosis,
Therapeutic Approach in Patients with Diabetes and Coronary Artery Disease
Home SVCC Area: English - Español - Português Therapeutic Approach in Patients with Diabetes and Coronary Artery Disease Martial G. Bourassa, MD Research Center, Montreal Heart Institute, Montreal, Quebec,
Cardiovascular System & Its Diseases. Lecture #4 Heart Failure & Cardiac Arrhythmias
Cardiovascular System & Its Diseases Lecture #4 Heart Failure & Cardiac Arrhythmias Dr. Derek Bowie, Department of Pharmacology & Therapeutics, Room 1317, McIntyre Bldg, McGill University derek.bowie@mcgill.ca
National Medicines Information Centre
National Medicines Information Centre ST. JAMES S HOSPITAL DUBLIN 8 TEL 01-4730589 or 1850-727-727 FAX 01-4730596 www.nmic.ie THE CONTEMPORARY MANAGEMENT OF ATRIAL FIBRILLATION VOLUME 12 NUMBER 3 2006
Mar. 31, 2011 (202) 690-6145. Improving Quality of Care for Medicare Patients: Accountable Care Organizations
DEPARTMENT OF HEALTH & HUMAN SERVICES Centers for Medicare & Medicaid Services Room 352-G 200 Independence Avenue, SW Washington, DC 20201 Office of Media Affairs MEDICARE FACT SHEET FOR IMMEDIATE RELEASE
Present : PGY 王 淳 峻 Supervisor: F1 王 德 皓 991109
Present : PGY 王 淳 峻 Supervisor: F1 王 德 皓 991109 Interventions to prevent cardiac arrest + Airway management + Ventilation support + Treatment of bradyarrhythmias & Tachyarrhythmias Treat cardiac arrest
Potential Causes of Sudden Cardiac Arrest in Children
Potential Causes of Sudden Cardiac Arrest in Children Project S.A.V.E. When sudden death occurs in children, adolescents and younger adults, heart abnormalities are likely causes. These conditions are
Atrial Fibrillation An update on diagnosis and management
Dr Arvind Vasudeva Consultant Cardiologist Atrial Fibrillation An update on diagnosis and management Atrial fibrillation (AF) remains the commonest disturbance of cardiac rhythm seen in clinical practice.
Antiplatelet and Antithrombotics From clinical trials to guidelines
Antiplatelet and Antithrombotics From clinical trials to guidelines Ashraf Reda, MD, FESC Prof and head of Cardiology Dep. Menofiya University Preisedent of EGYBAC Chairman of WGLVR One of the big stories
URN: Family name: Given name(s): Address:
The State of Queensland (Queensland Health) 2012 Contact CIM@health.qld.gov.au Facility: Clinical Pathways Never Replace Clinical Judgement Care Outlined In This Pathway Must be Altered If It Is Not Clinically
GUIDELINE 11.9 MANAGING ACUTE DYSRHYTHMIAS. (To be read in conjunction with Guideline 11.7 Post-Resuscitation Therapy in Adult Advanced Life Support)
AUSTRALIAN RESUSCITATION COUNCIL GUIDELINE 11.9 MANAGING ACUTE DYSRHYTHMIAS (To be read in conjunction with Guideline 11.7 Post-Resuscitation Therapy in Adult Advanced Life Support) The term cardiac arrhythmia
Official Online ACLS Exam
\ Official Online ACLS Exam Please fill out this form before you take the exam. Name : Email : Phone : 1. Hypovolemia initially produces which arrhythmia? A. PEA B. Sinus tachycardia C. Symptomatic bradyarrhythmia
4/7/2015. Cardiac Rehabilitation: From the other side of the glass door. Chicago, circa 1999. Objectives. No disclosures, no conflicts
Cardiac Rehabilitation: From the other side of the glass door No disclosures, no conflicts Charles X. Kim, MD, FACC, ABVM Objectives 1. Illustrate common CV benefits of CV rehab in real world practice.
ANNE ARUNDEL MEDICAL CENTER CRITICAL CARE MEDICATION MANUAL DEPARTMENT OF NURSING AND PHARMACY. Guidelines for Use of Intravenous Isoproterenol
ANNE ARUNDEL MEDICAL CENTER CRITICAL CARE MEDICATION MANUAL DEPARTMENT OF NURSING AND PHARMACY Guidelines for Use of Intravenous Isoproterenol Major Indications Status Asthmaticus As a last resort for
DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) MANAGEMENT of Atrial Fibrillation (AF)
DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) MANAGEMENT of Atrial Fibrillation (AF) Key priorities Identification and diagnosis Treatment for persistent AF Treatment for permanent AF Antithrombotic
Clinical Quality Measure Crosswalk: HEDIS, Meaningful Use, PQRS, PCMH, Beacon, 10 SOW
Clinical Crosswalk: HEDIS, Meaningful Use, PQRS, PCMH, Beacon, 10 SOW NQF 0105 PQRS 9 NQF 0002 PQRS 66 Antidepressant Medication Management Appropriate Testing for Children with Pharyngitis (2-18 years)
ACCIDENT AND EMERGENCY DEPARTMENT/CARDIOLOGY
Care Pathway Triage category ATRIAL FIBRILLATION PATHWAY ACCIDENT AND EMERGENCY DEPARTMENT/CARDIOLOGY AF/ FLUTTER IS PRIMARY REASON FOR PRESENTATION YES NO ONSET SYMPTOMS OF AF./../ TIME DURATION OF AF
Presenter Disclosure Information
2:15 3 pm Managing Arrhythmias in Primary Care Presenter Disclosure Information The following relationships exist related to this presentation: Raul Mitrani, MD, FACC, FHRS: Speakers Bureau for Medtronic.
CHAPTER 9 DISEASES OF THE CIRCULATORY SYSTEM (I00-I99)
CHAPTER 9 DISEASES OF THE CIRCULATORY SYSTEM (I00-I99) March 2014 2014 MVP Health Care, Inc. CHAPTER 9 CHAPTER SPECIFIC CATEGORY CODE BLOCKS I00-I02 Acute rheumatic fever I05-I09 Chronic rheumatic heart
CARDIO/PULMONARY MEDICINE FOR PRIMARY CARE. Las Vegas, Nevada Bellagio March 4 6, 2016. Participating Faculty
CARDIO/PULMONARY MEDICINE FOR PRIMARY CARE Las Vegas, Nevada Bellagio March 4 6, 2016 Participating Faculty Friday, March 4th: 7:30 am - 8:00 am Registration and Hot Breakfast 8:00 am - 9:00 am Pulmonary
Current Management of Atrial Fibrillation DISCLOSURES. Heart Beat Anatomy. I have no financial conflicts to disclose
Current Management of Atrial Fibrillation Mary Macklin, MSN, APRN Concord Hospital Cardiac Associates DISCLOSURES I have no financial conflicts to disclose Book Women: Fit at Fifty. A Guide to Living Long.
Treatments to Restore Normal Rhythm
Treatments to Restore Normal Rhythm In many instances when AF causes significant symptoms or is negatively impacting a patient's health, the major goal of treatment is to restore normal rhythm and prevent
An Introduction to Tachyarrhythmias R. A. Seyon MN, NP, CCN(C) & Dr. R. G. Williams
Arrhythmias 1 An Introduction to Tachyarrhythmias R. A. Seyon MN, NP, CCN(C) & Dr. R. G. Williams Things to keep in mind when analyzing arrhythmias: Electrical activity recorded in 12 and 15 leads Examine
6.3. Management 6.3.1. Routine Measures
ACC/AHA 2004 Practice Guidelines for STEMI 6.3. Management 6.3.1. Routine Measures 6.3.1.1. Oxygen Supplemental oxygen should be administered to patients with arterial oxygen desaturation (SaO2 less than
A PATIENT S GUIDE TO SECONDARY PREVENTION IN ACUTE CORONARY SYNDROME (ACS)
A PATIENT S GUIDE TO SECONDARY PREVENTION IN ACUTE CORONARY SYNDROME (ACS) This medicine is subject to additional monitoring. This will allow quick identification of new safety information. If you get
Medical Tourism - The Role of Intervals inCardiovascular Cancer
Acute Decompensated Heart Failure: Time Critical Interventions MO-51 / 1 Hour Faculty: Matthew Strehlow, MD, FACEP Monday, 10/26/2015 / 3:30 PM - 4:20 PM The treatment of congestive heart failure (CHF)
Hypertension and Heart Failure Medications. Dr William Dooley
Hypertension and Heart Failure Medications Dr William Dooley Plan Heart Failure Acute vs. chronic Mx Hypertension Common drugs used Method of action Choice of medications Heart Failure Aims; Short term:
How To Understand What You Know
Heart Disorders Glossary ABG (Arterial Blood Gas) Test: A test that measures how much oxygen and carbon dioxide are in the blood. Anemia: A condition in which there are low levels of red blood cells in
Bayer Extends Clinical Investigation of Rivaroxaban into Important Areas of Unmet Medical Need in Arterial Thromboembolism
Investor News Not intended for U.S. and UK Media Bayer AG Investor Relations 51368 Leverkusen Germany www.investor.bayer.com Bayer Extends Clinical Investigation of Rivaroxaban into Important Areas of
Cardiovascular Risk in Diabetes
Cardiovascular Risk in Diabetes Lipids Hypercholesterolaemia is an important reversible risk factor for cardiovascular disease and should be tackled aggressively in all diabetic patients. In Type 1 patients,
RISK STRATIFICATION for Acute Coronary Syndrome in the Emergency Department
RISK STRATIFICATION for Acute Coronary Syndrome in the Emergency Department Sohil Pothiawala FAMS (EM), MRCSEd (A&E), M.Med (EM), MBBS Consultant Dept. of Emergency Medicine Singapore General Hospital
Prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (AF) with one or more risk factors
News Release For use outside the US and UK only Bayer Pharma AG 13342 Berlin Germany Tel. +49 30 468-1111 www.bayerpharma.com Bayer s Xarelto Approved in the EU for the Prevention of Stroke in Patients
Preparing for ICD-10 for Physicians
Preparing for ICD-10 for Physicians May 2011 Notices These coding suggestions and coverage guidelines do not replace seeking coding advice from the payer and/or your coding staff. The ultimate responsibility
Acute Coronary Syndrome. What Every Healthcare Professional Needs To Know
Acute Coronary Syndrome What Every Healthcare Professional Needs To Know Background of ACS Acute Coronary Syndrome (ACS) is an umbrella term used to cover a spectrum of clinical conditions that are caused
Visited 9/14/2011. What is Atrial Fibrillation? What you need to know about Atrial Fibrillation. The Normal Heart Rhythm. 1 of 7 9/14/2011 10:50 AM
1 of 7 9/14/2011 10:50 AM Current URL: What you need to know about Atrial Fibrillation What is atrial fibrillation? What causes atrial fibrillation? How is atrial fibrillation diagnosed? What are the dangers
GENERAL HEART DISEASE KNOW THE FACTS
GENERAL HEART DISEASE KNOW THE FACTS WHAT IS Heart disease is a broad term meaning any disease affecting the heart. It is commonly used to refer to coronary heart disease (CHD), a more specific term to
Drug Treatment in Type 2 Diabetes with Hypertension
Hypertension is 1.5 2 times more prevalent in Type 2 diabetes (prevalence up to 80 % in diabetic subjects). This exacerbates the risk of cardiovascular disease by ~ two-fold. Drug therapy reduces the risk
Managing the Patient with Atrial Fibrillation
Pocket Guide Managing the Patient with Atrial Fibrillation Updated April 2012 Editor Stephen R. Shorofsky, MD, Ph.D. Assistant Editors Anastasios Saliaris, MD Shawn Robinson, MD www.hrsonline.org DEFINITION
Bayer Initiates Rivaroxaban Phase III Study to Support Dose Selection According to Individual Benefit-Risk Profile in Long- Term VTE Prevention
Investor News Not intended for U.S. and UK Media Bayer AG Investor Relations 51368 Leverkusen Germany www.investor.bayer.com Long-term prevention of venous blood clots (VTE): Bayer Initiates Rivaroxaban
DISCLOSURES RISK ASSESSMENT. Stroke and Heart Disease -Is there a Link Beyond Risk Factors? Daniel Lackland, MD
STROKE AND HEART DISEASE IS THERE A LINK BEYOND RISK FACTORS? D AN IE L T. L AC K L AN D DISCLOSURES Member of NHLBI Risk Assessment Workgroup RISK ASSESSMENT Count major risk factors For patients with
Medtronic Cardiac Rhythm and Heart Failure ICD-10 Coding for Physicians
Medtronic Cardiac Rhythm and Heart Failure ICD-10 Coding for Physicians May 19, 2015 Disclaimer This presentation is intended for educational use. Any duplication is prohibited without written consent
HTEC 91. Topic for Today: Atrial Rhythms. NSR with PAC. Nonconducted PAC. Nonconducted PAC. Premature Atrial Contractions (PACs)
HTEC 91 Medical Office Diagnostic Tests Week 4 Topic for Today: Atrial Rhythms PACs: Premature Atrial Contractions PAT: Paroxysmal Atrial Tachycardia AF: Atrial Fibrillation Atrial Flutter Premature Atrial
Cardiac Rehabilitation (Outpatient Phase II) Corporate Medical Policy. Medical Policy
Cardiac Rehabilitation (Outpatient Phase II) Corporate Medical Policy File name: Cardiac Rehabilitation (Outpatient Phase II) File code: UM.REHAB.04 Origination: 08/1994 Last Review: 08/2011 Next Review:
Atrial & Junctional Dysrhythmias
Atrial & Junctional Dysrhythmias Atrial & Junctional Dysrhythmias Atrial Premature Atrial Complex Wandering Atrial Pacemaker Atrial Tachycardia (ectopic) Multifocal Atrial Tachycardia Atrial Flutter Atrial
Management of Acute Coronary Syndrome / NSTEMI
CLINICAL GUIDELINE Management of Acute Coronary Syndrome / NSTEMI For use in (clinical areas): For use by (staff groups): For use for (patients): Document owner: Status: All clinical areas Medical and
Cardiovascular diseases. pathology
Cardiovascular diseases pathology Atherosclerosis Vascular diseases A disease that results in arterial wall thickens as a result of build- up of fatty materials such cholesterol, resulting in acute and
COVERAGE GUIDANCE: ABLATION FOR ATRIAL FIBRILLATION
COVERAGE GUIDANCE: ABLATION FOR ATRIAL FIBRILLATION Question: How should the EGBS Coverage Guidance regarding ablation for atrial fibrillation be applied to the Prioritized List? Question source: Evidence
CLINICAL GUIDELINE FOR SECONDARY PREVENTION AFTER STROKE OR TIA (PRIMARY AND SECONDARY CARE CORNWALL) MANAGEMENT 1. Aim/Purpose of this Guideline
CLINICAL GUIDELINE FOR SECONDARY PREVENTION AFTER STROKE OR TIA (PRIMARY AND SECONDARY CARE CORNWALL) MANAGEMENT 1. Aim/Purpose of this Guideline The aim of this document to inform clinicians on management
Treatment of cardiogenic shock
ACUTE HEART FAILURE AND COMORBIDITY IN THE ELDERLY Treatment of cardiogenic shock Christian J. Wiedermann, M.D., F.A.C.P. Associate Professor of Internal Medicine, Medical University of Innsbruck, Austria
Guidelines for Use of Clopidogrel (Plavix )
East Lancashire Medicines Management Board representing East Lancashire Hospitals NHS Trust, Lancashire Care Trust, Blackburn with Darwen PCT, East Lancs PCT Licensed Indications Guidelines for Use of
Perioperative Cardiac Evaluation
Perioperative Cardiac Evaluation Caroline McKillop Advisor: Dr. Tam Psenka 10-3-2007 Importance of Cardiac Guidelines -Used multiple times every day -Patient Safety -Part of Surgical Care Improvement Project
A Patient s Guide to Primary and Secondary Prevention of Cardiovascular Disease Using Blood-Thinning (Anticoagulant) Drugs
A Patient s Guide to Primary and Secondary Prevention of PATIENT EDUCATION GUIDE What Is Cardiovascular Disease? Cardiovascular disease (CVD) is a broad term that covers any disease of the heart and circulatory
Automatic External Defibrillators
Last Review Date: May 27, 2016 Number: MG.MM.DM.10dC2 Medical Guideline Disclaimer Property of EmblemHealth. All rights reserved. The treating physician or primary care provider must submit to EmblemHealth
Ischemia and Infarction
Harvard-MIT Division of Health Sciences and Technology HST.035: Principle and Practice of Human Pathology Dr. Badizadegan Ischemia and Infarction HST.035 Spring 2003 In the US: ~50% of deaths are due to
Anticoagulant therapy
Anticoagulation: The risks Anticoagulant therapy 1990 2002: 600 incidents reported 120 resulted in death of patient 92 deaths related to warfarin usage 28 reports related to heparin usage Incidents in
Atrial Fibrillation: Drugs, Ablation, or Benign Neglect. Robert Kennedy, MD October 10, 2015
Atrial Fibrillation: Drugs, Ablation, or Benign Neglect Robert Kennedy, MD October 10, 2015 Definitions 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary.
Clinical Guideline for the Management of Pot Operative Atrial Fibrillation
Clinical Guideline for the Management of Pot Operative Atrial Fibrillation 1. Aim/Purpose of this Guideline 1.1. Atrial Fibrillation is the most common cardiac arrhythmia with a prevalence of around 0.5%
Bayer Pharma AG 13342 Berlin Germany Tel. +49 30 468-1111 www.bayerpharma.com. News Release. Not intended for U.S. and UK Media
News Release Not intended for U.S. and UK Media Bayer Pharma AG 13342 Berlin Germany Tel. +49 30 468-1111 www.bayerpharma.com Bayer Forms Collaboration with Academic and Governmental Institutions for Rivaroxaban
ACUTE ATRIAL FIBRILLATION TREATMENT IN THE SURGICAL PATIENT
DISCLAIMER: These guidelines were prepared by the Department of Surgical Education, Orlando Regional Medical Center. They are intended to serve as a general statement regarding appropriate patient care
SIGN 93 Acute coronary syndromes. A national clinical guideline Updated February 2013
Help us to improve SIGN guidelines - click here to complete our survey SIGN 93 Acute coronary syndromes A national clinical guideline Updated February 2013 Evidence KEY TO EVIDENCE STATEMENTS AND GRADES
NORTHERN NETWORK OF CARDIAC CARE GUIDELINES FOR THE DETECTION AND MANAGEMENT OF ATRIAL FIBRILLATION (AF)
NORTHERN NETWORK OF CARDIAC CARE GUIDELINES FOR THE DETECTION AND MANAGEMENT OF ATRIAL FIBRILLATION (AF) These notes should be read in conjunction with the summary algorithms July 2007 CONTENTS 1. Introduction
8-9-2012. In hospital diabetes care background and challenges. Duality of interest. One of the goals may be...
In hospital diabetes care background and challenges Duality of interest Nothing to disclose within the framework of this presentation My own fasting BG is 4.6 mmol/l, HbA1c 5.4% Bruce H.R. Wolffenbuttel
Chest Pain. Acute Myocardial Infarction: Differential Diagnosis and Patient Management. Common complaint in ED. Wide range of etiologies
Acute Myocardial Infarction: Differential Diagnosis and Patient Management Presented By: Barbara Furry, RN-BC, MS, CCRN, FAHA Director The Center of Excellence in Education Director of HERO Chest Pain
Cardioversion for. Atrial Fibrillation. Your Heart s Electrical System Cardioversion Living with Atrial Fibrillation
Cardioversion for Atrial Fibrillation Your Heart s Electrical System Cardioversion Living with Atrial Fibrillation When You Have Atrial Fibrillation You ve been told you have a heart condition called atrial
Long term anticoagulant therapy in patients with atrial fibrillation at high risk of stroke: a new scenario after RE-LY trial
Long term anticoagulant therapy in patients with atrial fibrillation at high risk of stroke: a new scenario after RE-LY trial Camillo Autore Università di Roma Sapienza II Facoltà di Medicina e Chirurgia
American Heart Association ACLS Pre-Course Self Assessment Dec., 2006. ECG Analysis. Name the following rhythms from the list below:
American Heart Association ACLS Pre-Course Self Assessment Dec., 2006 ECG Analysis This pre-test is exactly the same as the pretest on the ACLS Provider manual CD. This paper version can be completed in
Atrial Fibrillation The Basics
Atrial Fibrillation The Basics Family Practice Symposium Tim McAveney, M.D. 10/23/09 Objectives Review the fundamentals of managing afib Discuss the risks for stroke and the indications for anticoagulation
Universitätsklinik für Kardiologie. Test. Thomas M. Suter Akute Herzinsuffizienz Diagnostik und Therapie thomas.suter@insel.ch 1
Test Thomas M. Suter Akute Herzinsuffizienz Diagnostik und Therapie thomas.suter@insel.ch 1 Heart Failure - Definition European Heart Journal (2008) 29, 2388 2442 Akute Herzinsuffizienz Diagnostik und
Duration of Dual Antiplatelet Therapy After Coronary Stenting
Duration of Dual Antiplatelet Therapy After Coronary Stenting C. DEAN KATSAMAKIS, DO, FACC, FSCAI INTERVENTIONAL CARDIOLOGIST ADVOCATE LUTHERAN GENERAL HOSPITAL INTRODUCTION Coronary artery stents are
Atrial fibrillation (AF) care pathways. for the primary care physicians
Atrial fibrillation (AF) care pathways for the primary care physicians by University of Minnesota Physicians Heart, October, 2011 Evaluation by the primary care physician: 1. Comprehensive history and
- Appreciate the importance of chest pain as a presenting symptom. - Feel more confident about the recognition and early management of chest pain
Acute Chest Pain Objectives By reading this material you should be able to - Appreciate the importance of chest pain as a presenting symptom - Feel more confident about the recognition and early management
Recurrent AF: Choosing the Right Medication.
In the name of God Shiraz E-Medical Journal Vol. 11, No. 3, July 2010 http://semj.sums.ac.ir/vol11/jul2010/89015.htm Recurrent AF: Choosing the Right Medication. Basamad Z. * Assistant Professor, Department
ACLS Provider Manual Comparison Sheet Based on 2010 AHA Guidelines for CPR and ECC. BLS Changes
ACLS Provider Manual Comparison Sheet Based on 2010 AHA Guidelines for CPR and ECC CPR Chest compressions, Airway, Breathing (C-A-B) BLS Changes New Old Rationale New science indicates the following order:
Surgery and Anti-Coagulation Agents
CLINICAL GUIDELINE For use in (clinical areas): For use by (staff groups): For use for (patients): Document owner: Status: Pre-admission clinics and surgical wards Personnel involved in surgical pre-assessment
New Oral Anticoagulants. How safe are they outside the trials?
New Oral Anticoagulants How safe are they outside the trials? Objectives The need for anticoagulant therapy Indications for anticoagulation Traditional anticoagulant therapies Properties of new oral anticoagulants
Normal Sinus Rhythm. Sinus Bradycardia. Sinus Tachycardia. Rhythm ECG Characteristics Example (NSR) & consistent. & consistent.
Normal Sinus Rhythm (NSR) Rate: 60-100 per minute Rhythm: R- R = P waves: Upright, similar P-R: 0.12-0.20 second & consistent P:qRs: 1P:1qRs Sinus Tachycardia Exercise Hypovolemia Medications Fever Hypoxia
convey the clinical quality measure's title, number, owner/developer and contact
CMS-0033-P 153 convey the clinical quality measure's title, number, owner/developer and contact information, and a link to existing electronic specifications where applicable. TABLE 20: Proposed Clinical
ATRIAL FIBRILLATION IN THE 21 ST CENTURY TIMOTHY DOWLING, D.O. FAMILY PHYSICIAN
ATRIAL FIBRILLATION IN THE 21 ST CENTURY TIMOTHY DOWLING, D.O. FAMILY PHYSICIAN GOALS AND OBJECTIVES At The end of this talk you should understand: What is Atrial Fibrillation Causes of Atrial Fibrillation
Cardiology. Physician and Paediatrician Training Program Cardiology Advanced Training Curriculum
Cardiology Physician and Paediatrician Training Program Cardiology Advanced Training Curriculum Advanced Training Curriculum To be used in conjunction with: Basic Training Curricula Adult Internal Medicine
What Do Guidelines Say We Should Do in Patients with ST Elevation Myocardial Infarction?
Review 199 THE JOURNAL OF ACADEMIC EMERGENCY MEDICINE What Do Guidelines Say We Should Do in Patients with ST Elevation Myocardial Infarction? Onur Akpınar 1, Ayça Açıkalın 2, Nezihat Rana Dişel 2, Çağlar
Cardiology ARCP Decision Aid August 2014
Cardiology ARCP Decision Aid August 2014 The table that follows includes a column for each training year which documents the targets that have to be achieved for a satisfactory ARCP outcome at the end
Guideline for the management of arrhythmias
Guideline for the management of arrhythmias The following guideline is approved only for use at University College London Hospitals NHS Foundation Trust. It is provided as supporting information for the